Drug Approval | September 05, 2025
FDA expands medtronic MiniMed 780G system
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Subscribe To Our Newsletter & Stay Updated
